Academic literature on the topic 'Astemizol'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Astemizol.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Astemizol"

1

Horak, F., S. Jäcer, and U. Berger. "Onset and Duration of the Effects of Three Antihistamines in Current Use – Astemizole, Loratadine and Terfenadine Forte – Studied during Prolonged, Controlled Allergen Challenges in Volunteers." Journal of International Medical Research 20, no. 5 (1992): 422–34. http://dx.doi.org/10.1177/030006059202000507.

Full text
Abstract:
In a three-way, double-blind, crossover study the onset of action and effects at the end of the dosing interval of 10 mg/day astemizole, 10 mg/day loratadine and 120 mg/day terfenadine forte given for 3 days to six atopic volunteers were assessed using the Vienna challenge chamber (VCC). With each treatment, two long-term pollen challenges were performed in the VCC: the first to assess the onset of action started 1 h before the first dose and lasted continuously for 5 h; the second to assess the effects at the end of dosing took place 21 h after the last of the three doses and lasted 3 h. All
APA, Harvard, Vancouver, ISO, and other styles
2

Larenas-Linnemann, Désirée, Mario Sánchez-Borges, Blanca Estela Del Río-Navarro, et al. "Antihistamínicos en el tratamiento de la urticaria en México." Revista Alergia México 62, no. 3 (2021): 157–74. http://dx.doi.org/10.29262/ram.v62i3.103.

Full text
Abstract:
Existen cuatro tipos de receptores histaminérgicos. Los síntomas de alergia, especialmente rinoconjuntivitis alérgica y urticaria, son principalmente causados por activación del receptor H1; por ende, los antihistamínicos H1 orales (anti-H1) forman parte integral del tratamiento de estas enfermedades. Los antihistamínicos son agonistas inversos, porque estabilizan la forma inactiva del receptor. Los antihistamínicos H1 de primera generación producen efectos adversos por varios mecanismos: sedación (fijación a receptores H1 cerebrales), boca seca, retención urinaria, aumento de peso (baja selec
APA, Harvard, Vancouver, ISO, and other styles
3

Laine, Kari, Kari T. Kivistö, and Pertti J. Neuvonen. "The Effect of Activated Charcoal on the Absorption and Elimination of Astemizole." Human & Experimental Toxicology 13, no. 7 (1994): 502–5. http://dx.doi.org/10.1177/096032719401300709.

Full text
Abstract:
1 The effect of activated charcoal on the absorption and elimination of astemizole and its metabolites was studied in healthy volunteers. 2 Subjects were divided into three groups containing seven subjects each. One group received 30 mg of astemizole with water only (control) and another group with 25 g of activated charcoal. The third group received multiple doses (12 g) of charcoal from 6 h onwards twice daily for 8 days. The concentrations of astemizole and its metabolites in plasma were measured by radioimmunoassay for 192 h. 3 Activated charcoal, administered immediately after astemizole
APA, Harvard, Vancouver, ISO, and other styles
4

Al-Muhaimeed, H. "A Parallel-Group Comparison of Astemizole and Loratadine for the Treatment of Perennial Allergic Rhinitis." Journal of International Medical Research 25, no. 4 (1997): 175–81. http://dx.doi.org/10.1177/030006059702500401.

Full text
Abstract:
The efficacy and safety of the two antihistamines, astemizole and loratadine, were compared in a double-blind study of 84 patients with perennial allergic rhinitis. Patients were randomized to receive orally either astemizole 10 mg once daily ( n = 40) or loratadine 10 mg once daily ( n = 44) for 1 week. No other antirhinitis medication was allowed during the study. By day 7 the mean daily symptom scores, recorded on diary cards, were lower in patients receiving astemizole than in those receiving loratadine for runny nose, itchy nose and sneezing, although not for blocked nose, and treatment d
APA, Harvard, Vancouver, ISO, and other styles
5

Krstenansky, Patrice M., and Robert J. Cluxton. "Astemizole: A Long-Acting, Nonsedating Antihistamine." Drug Intelligence & Clinical Pharmacy 21, no. 12 (1987): 947–53. http://dx.doi.org/10.1177/106002808702101202.

Full text
Abstract:
Astemizole is a long-acting, highly selective histamine1-receptor antagonist with minimal central and anticholinergic effects. Comparison studies have shown astemizole to be equal or superior to currently available antihistamines, beclomethasone nasal spray, and cromolyn sodium in relieving allergic symptoms of seasonal and perennial allergic rhinitis. Other uses include treatment of allergic conjunctivitis and chronic urticaria. Astemizole is not as effective for treatment of acute allergic symptoms because of its delayed onset of action. Astemizole and its active metabolite, desmethylastemiz
APA, Harvard, Vancouver, ISO, and other styles
6

&NA;. "Astemizole." Reactions Weekly &NA;, no. 460 (1993): 6. http://dx.doi.org/10.2165/00128415-199304600-00022.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

&NA;. "Astemizole." Reactions Weekly &NA;, no. 462 (1993): 5. http://dx.doi.org/10.2165/00128415-199304620-00018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

&NA;. "Astemizole." Reactions Weekly &NA;, no. 468 (1993): 5. http://dx.doi.org/10.2165/00128415-199304680-00019.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

&NA;. "Astemizole." Reactions Weekly &NA;, no. 320 (1990): 4. http://dx.doi.org/10.2165/00128415-199003200-00007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

&NA;. "Astemizole." Reactions Weekly &NA;, no. 695 (1998): 6. http://dx.doi.org/10.2165/00128415-199806950-00014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Astemizol"

1

Weinschenck, Hans Peter. "Astemizol und Terfenadin : Bedeutung physikochemischer Eigenschaften für Pharmakodynamik und Pharmakokinetik /." [S.l. : s.n.], 1994. http://www.gbv.de/dms/bs/toc/180465406.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

DA, ROCHA BERTRAND. "Torsades de pointe sous astemizole : revelation d'une forme fruste du syndrome du qt long familial : a propos de deux observations." Lille 2, 1992. http://www.theses.fr/1992LIL2M300.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ho, Danny Ka Hei. "Palladium(II)-catalysed sp 3 C–H functionalisation of hindered amines and its application in synthesis of astemizole analogues." Thesis, University of Cambridge, 2016. https://www.repository.cam.ac.uk/handle/1810/267480.

Full text
Abstract:
The development of a palladium-catalysed C–H carbonylation of hindered secondary amines is described. Central to this strategy is the temporary conversion of simple ketones into hindered secondary amines that facilitates a sterically promoted palladium-catalysed C–H activation. A range of functional groups are shown to be compatible with this catalytic process, and with exclusive regioselectivity for the terminal ethyl sp 3 C–H in most cases. This method allows an overall incorporation of a carboxyl group to the b-position of terminal ketones, generating 1,4- dicarbonyl moieties which are impo
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Astemizol"

1

Clive, Wood, and Royal Society of Medicine (Great Britain), eds. Astemizole in asthma. Royal Society of Medicine Services, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Astemizole in Asthma (International Congress & Symposium Series (ICSS)). Royal Society of Medicine Press Ltd, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Astemizol"

1

Beyer, Karl-Heinz. "Astemizol." In Biotransformation der Arzneimittel. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-74386-3_29.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Day, J. H., D. Buckeridge, M. Briscoe, A. Welsh, and J. A. Buttars. "Onset of Action and Efficacy of Astemizole, Cetirizine, Loratadine, and Terfenadine as Tested by Controlled Antigen Challenge in an Environmental Exposure Unit." In New Trends in Allergy IV. Springer Berlin Heidelberg, 1997. http://dx.doi.org/10.1007/978-3-642-60419-5_60.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Reed, Michael D. "Astemizole." In Encyclopedia of Toxicology. Elsevier, 2005. http://dx.doi.org/10.1016/b0-12-369400-0/00092-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Shafiee, A., and M. Khoobi. "Astemizole." In Encyclopedia of Toxicology. Elsevier, 2014. http://dx.doi.org/10.1016/b978-0-12-386454-3.00694-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jewell, Richard. "Astemizole." In xPharm: The Comprehensive Pharmacology Reference. Elsevier, 2007. http://dx.doi.org/10.1016/b978-008055232-3.61257-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

"Astemizole." In Meyler's Side Effects of Drugs. Elsevier, 2016. http://dx.doi.org/10.1016/b978-0-444-53717-1.00334-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

"Astemizole." In Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Elsevier, 2006. http://dx.doi.org/10.1016/b0-44-451005-2/00637-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Al-Obaid, Abdulrahman M., and Mohammad Saleem Mian. "Analytical Profile of Astemizole." In Analytical Profiles of Drug Substances. Elsevier, 1991. http://dx.doi.org/10.1016/s0099-5428(08)60531-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Astemizol"

1

García, J., R. García, O. Villanueva, et al. "Abstract P4-06-19: Astemizole and calcitriol: A novel targeted therapeutic strategy for breast cancer." In Abstracts: Thirty-Fifth Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 4‐8, 2012; San Antonio, TX. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/0008-5472.sabcs12-p4-06-19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!